AC
ACER

Armistice Capital’s Acer Therapeutics Inc ACER Stock Holding History

Armistice Capital’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,204,694
Closed -$1.67M – 287
2023
Q1 		$1.67M Buy
+2,204,694
New +$4.35M 0.02% 130

Other funds holding ACER

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HAIM
Hunter Associates Investment Management Pittsburgh, Pennsylvania $868M AUM 32.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital's ACER Position: Q2 2023 in Review

Armistice Capital sold out of Acer Therapeutics Inc (ACER) in Q2 2023, closing a stake of 2,204,694 shares — an estimated $1.67M sold.

Armistice Capital first reported a position in ACER in Q1 2023 and held it in 1 quarter. The position peaked at $1.67M in Q1 2023. 28 funds tracked by Wall St. Rank hold ACER as of Q2 2023.

  • Armistice Capital reported no remaining Acer Therapeutics Inc position as of Q2 2023 after selling out during the quarter.
  • Armistice Capital sold 2,204,694 Acer Therapeutics Inc shares in Q2 2023, an estimated $1.67M.
  • Armistice Capital first reported a position in Acer Therapeutics Inc in Q1 2023 and held it in 1 quarter.
  • Armistice Capital's Acer Therapeutics Inc position peaked at $1.67M in Q1 2023.
  • 28 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2023.

Based on Armistice Capital's 13F filing for Q2 2023, filed 14 Aug 2023.